Peter Cherutich1, Matthew R Golden2, Beatrice Wamuti3, Barbra A Richardson4, Kristjana H Ásbjörnsdóttir5, Felix A Otieno3, Ann Ng'ang'a6, Peter Maingi Mutiti3, Paul Macharia6, Betsy Sambai3, Matt Dunbar7, David Bukusi3, Carey Farquhar8. 1. National AIDS/Sexually Transmitted Diseases Control Programme, Ministry of Health, Nairobi, Kenya. Electronic address: pcheru@uw.edu. 2. Department of Medicine, University of Washington, Seattle, WA, USA. 3. Department of Research and Training, Kenyatta National Hospital, Nairobi, Kenya. 4. Department of Global Health, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA. 5. Department of Global Health, University of Washington, Seattle, WA, USA. 6. National AIDS/Sexually Transmitted Diseases Control Programme, Ministry of Health, Nairobi, Kenya. 7. Department of Computer Science and Demography, University of Washington, Seattle, WA, USA. 8. Department of Medicine, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: Assisted partner services for index patients with HIV infections involves elicitation of information about sex partners and contacting them to ensure that they test for HIV and link to care. Assisted partner services are not widely available in Africa. We aimed to establish whether or not assisted partner services increase HIV testing, diagnoses, and linkage to care among sex partners of people with HIV infections in Kenya. METHODS: In this cluster randomised controlled trial, we recruited non-pregnant adults aged at least 18 years with newly or recently diagnosed HIV without a recent history of intimate partner violence who had not yet or had only recently linked to HIV care from 18 HIV testing services clinics in Kenya. Consenting sites in Kenya were randomly assigned (1:1) by the study statistician (restricted randomisation; balanced distribution in terms of county and proximity to a city) to immediate versus delayed assisted partner services. Primary outcomes were the number of partners tested for HIV, the number who tested HIV positive, and the number enrolled in HIV care, in those who were interviewed at 6 week follow-up. Participants within each cluster were masked to treatment allocation because participants within each cluster received the same intervention. This trial is registered with ClinicalTrials.gov, number NCT01616420. FINDINGS:Between Aug 12, 2013, and Aug 31, 2015, we randomly allocated 18 clusters to immediate and delayed HIV assisted partner services (nine in each group), enrolling 1305 participants: 625 (48%) in the immediate group and 680 (52%) in the delayed group. 6 weeks after enrolment of index patients, 392 (67%) of 586 partners had tested for HIV in the immediate group and 85 (13%) of 680 had tested in the delayed group (incidence rate ratio 4·8, 95% CI 3·7-6·4). 136 (23%) partners had new HIV diagnoses in the immediate group compared with 28 (4%) in the delayed group (5·0, 3·2-7·9) and 88 (15%) versus 19 (3%) were newly enrolled in care (4·4, 2·6-7·4). Assisted partner services did not increase intimate partner violence (one intimate partner violence event related to partner notification or study procedures occurred in each group). INTERPRETATION: Assisted partner services are safe and increase HIV testing and case-finding; implementation at the population level could enhance linkage to care and antiretroviral therapy initiation and substantially decrease HIV transmission. FUNDING: National Institutes of Health.
RCT Entities:
BACKGROUND: Assisted partner services for index patients with HIV infections involves elicitation of information about sex partners and contacting them to ensure that they test for HIV and link to care. Assisted partner services are not widely available in Africa. We aimed to establish whether or not assisted partner services increase HIV testing, diagnoses, and linkage to care among sex partners of people with HIV infections in Kenya. METHODS: In this cluster randomised controlled trial, we recruited non-pregnant adults aged at least 18 years with newly or recently diagnosed HIV without a recent history of intimate partner violence who had not yet or had only recently linked to HIV care from 18 HIV testing services clinics in Kenya. Consenting sites in Kenya were randomly assigned (1:1) by the study statistician (restricted randomisation; balanced distribution in terms of county and proximity to a city) to immediate versus delayed assisted partner services. Primary outcomes were the number of partners tested for HIV, the number who tested HIV positive, and the number enrolled in HIV care, in those who were interviewed at 6 week follow-up. Participants within each cluster were masked to treatment allocation because participants within each cluster received the same intervention. This trial is registered with ClinicalTrials.gov, number NCT01616420. FINDINGS: Between Aug 12, 2013, and Aug 31, 2015, we randomly allocated 18 clusters to immediate and delayed HIV assisted partner services (nine in each group), enrolling 1305 participants: 625 (48%) in the immediate group and 680 (52%) in the delayed group. 6 weeks after enrolment of index patients, 392 (67%) of 586 partners had tested for HIV in the immediate group and 85 (13%) of 680 had tested in the delayed group (incidence rate ratio 4·8, 95% CI 3·7-6·4). 136 (23%) partners had new HIV diagnoses in the immediate group compared with 28 (4%) in the delayed group (5·0, 3·2-7·9) and 88 (15%) versus 19 (3%) were newly enrolled in care (4·4, 2·6-7·4). Assisted partner services did not increase intimate partner violence (one intimate partner violence event related to partner notification or study procedures occurred in each group). INTERPRETATION: Assisted partner services are safe and increase HIV testing and case-finding; implementation at the population level could enhance linkage to care and antiretroviral therapy initiation and substantially decrease HIV transmission. FUNDING: National Institutes of Health.
Authors: Tamara Hoxworth; Nancy E Spencer; Thomas A Peterman; Thelma Craig; Solwazi Johnson; Julie E Maher Journal: Sex Transm Dis Date: 2003-01 Impact factor: 2.830
Authors: Lillian B Brown; William C Miller; Gift Kamanga; Naomi Nyirenda; Pearson Mmodzi; Audrey Pettifor; Rosalie C Dominik; Jay S Kaufman; Clement Mapanje; Francis Martinson; Myron S Cohen; Irving F Hoffman Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: R Baggaley; B Hensen; O Ajose; K L Grabbe; V J Wong; A Schilsky; Y-R Lo; F Lule; R Granich; J Hargreaves Journal: Bull World Health Organ Date: 2012-06-27 Impact factor: 9.408
Authors: Beatrice Muthoni Wamuti; Laura Kelly Erdman; Peter Cherutich; Matthew Golden; Matthew Dunbar; David Bukusi; Barbra Richardson; Anne Ng'ang'a; Ruanne Barnabas; Peter Maingi Mutiti; Paul Macharia; Mable Jerop; Felix Abuna Otieno; Danielle Poole; Carey Farquhar Journal: Implement Sci Date: 2015-02-13 Impact factor: 7.327
Authors: Marielle S Goyette; Peter M Mutiti; David Bukusi; Beatrice M Wamuti; Felix A Otieno; Peter Cherutich; Matthew R Golden; Hans Spiegel; Barbra A Richardson; Anne Ngʼangʼa; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731
Authors: Jillian Neary; Irene N Njuguna; Lisa M Cranmer; Vincent O Otieno; Cyrus Mugo; Hellen M Okinyi; Sarah Benki-Nugent; Barbra A Richardson; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart; Anjuli D Wagner Journal: AIDS Care Date: 2020-02-04
Authors: Marie-Huguette K A Kingbo; Petros Isaakidis; Arielle Lasry; Kudakwashe C Takarinda; Marcel Manzi; John Pringle; Flore A Konan; Jules N'Draman; Nathalie Krou Danho; Armand K Abokon; Nicole Isabelle L Doumatey Journal: Sex Transm Dis Date: 2020-05-20 Impact factor: 2.830
Authors: Monisha Sharma; Jennifer A Smith; Carey Farquhar; Roger Ying; Peter Cherutich; Matthew Golden; Beatrice Wamuti; David Bukusi; Hans Spiegel; Ruanne V Barnabas Journal: AIDS Date: 2018-01-14 Impact factor: 4.177
Authors: Katrina F Ortblad; Jared M Baeten; Peter Cherutich; Joyce Njeri Wamicwe; Judith N Wasserheit Journal: Curr Opin HIV AIDS Date: 2019-09 Impact factor: 4.283
Authors: Shirley J Semple; Heather A Pines; Steffanie A Strathdee; Alicia Harvey Vera; Gudelia Rangel; Carlos Magis-Rodriguez; Thomas L Patterson Journal: AIDS Behav Date: 2018-07